7,718.60

-29.11

-0.38%

53,414.25

-271.85

-0.51%

26,506.99

-77.11

-0.29%

2,975.65

+7.38

+0.25%

14.53

+0.21

+1.47%

4,476.60

-63.30

-1.39%

79,707.65

-94.36

-0.12%

Crude Oil Oct 26

91.48

+0.18

+0.20%

NasdaqCM - Delayed Quote USD

Tiziana Life Sciences Ltd (TLSA)

Get top stock picks

1.0200 +0.0455 (+4.67%)

At close: September 4 at 4:00:00 PM EDT

1.0100 -0.0100 (-0.98%)

After hours: September 4 at 7:30:02 PM EDT

Get top stock picks

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

Tiziana Life Sciences gets Buy rating from BTIG on Treg-based approach to neurodegeneration

Proactive 2d ago

TLSA
+4.67%
Tiziana Life Sciences to present Phase 2a BANYAN trial data at ALS Nexus 2026

Proactive 13d ago

TLSA
+4.67%
Tiziana Life Sciences Announces Poster Presentation on Phase 2a BANYAN Clinical Trial of Intranasal Foralumab at ALS Nexus 2026

GlobeNewswire 13d ago

TLSA
+4.67%
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer

GlobeNewswire 1mo ago

TLSA
+4.67%
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer

GlobeNewswire 1mo ago

TLSA
+4.67%
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer

GlobeNewswire 1mo ago

TLSA
+4.67%
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer

GlobeNewswire 1mo ago

TLSA
+4.67%
Tiziana Life Sciences reports reductions in brain inflammation in third MSA patient

Proactive 1mo ago

TLSA
+4.67%
Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab

GlobeNewswire 1mo ago

TLSA
+4.67%
Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman

GlobeNewswire 1mo ago

TLSA
+4.67%
Tiziana Life Sciences doses last patient in Phase 2a multiple sclerosis trial

Proactive 2mo ago

TLSA
+4.67%
Tiziana Announces Last Patient Successfully Dosed in its Phase 2 INFORM-MS Trial

GlobeNewswire 2mo ago

TLSA
+4.67%

Performance Overview

Return	TLSA	S&P 500 (^GSPC)
YTD	-31.54%	+12.75%
1-Year	-35.44%	+18.71%
3-Year	+34.21%	+70.93%

Mobilize your Website

View Site in Mobile | Classic

Share by: